Business Development

Bringing together innovation and opportunities in the pharmaceutical and biotech arena

Business Development (BD) has been established in the UK to bring together innovation and opportunities in the pharmaceutical and biotech arena to enhance the position of Grunenthal as a partner of choice.

BD identifies new opportunities from the external innovation community, in late-stage discovery or early clinical development, and assesses their commercial and medical value along with their ‘fit’ to the Grunenthal UK company culture and current and future product portfolio.

For more information and to discuss further, please contact Business Development at UKBusinessdevelopment@grunenthal.com or 014894 846240.